Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes

This publication has 54 references indexed in Scilit:

• HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma
  Cancer Cell, 2008
• Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through Hypoxia-inducible factor
  Oncogene, 2003
• Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
  Nature Cell Biology, 2002
• HIF activation identifies early lesions in VHL kidneys
  Cancer Cell, 2002
• Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype
  Proceedings of the National Academy of Sciences, 2002
• Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
  Cancer Cell, 2002
• Stem cells, cancer, and cancer stem cells
  Nature, 2001
• FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
  Genes & Development, 2001
• Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
  British Journal of Cancer, 2001
• Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
  Nature, 2000